Position in EXEL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$31,721
+$6,717 QoQ
Shares Held
583
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#631
of 756 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WealthCollab, LLC holds $168,856 across 19 Biotechnology names. EXEL ranks #1 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
583 | $31,721 | |
| 2 | INVA |
Innoviva, Inc.
|
1,288 | $29,250 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
69 | $16,626 | |
| 4 | MRNA |
Moderna, Inc.
|
200 | $14,006 | |
| 5 | ARGX |
Argenx SE
|
14 | $12,988 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
200 | $10,908 | |
| 7 | GMAB |
Genmab A/S
|
357 | $9,806 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
197 | $7,706 |
All Filings in EXEL
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,721 | 583 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $25,004 | 583 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $25,552 | 583 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $24,077 | 583 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $25,698 | 583 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $21,524 | 583 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $19,413 | 583 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,128 | 583 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,370 | 61 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,447 | 61 | Shares | Defined | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||